
“In our cohort, [diabetes mellitus] was a significant predictor of lower [erectile function recovery] at 2 years post-RP,” the authors wrote.

“In our cohort, [diabetes mellitus] was a significant predictor of lower [erectile function recovery] at 2 years post-RP,” the authors wrote.

“Results would suggest benefits with performing a full series of 4 CCH injections, even among men who are initial non-responders,” the authors concluded.

International Index of Erectile Function-Erectile Function (IIEF-EF) score increased in patients receiving nutraceuticals.

Investigators found that about one-fourth of men who underwent the “testosterone challenge” had a rise in PSA level.

As indicated by regression analysis, there was a significant association between the degree of penile curvature and status of uncontrolled diabetes mellitus.